Cargando…

[18F]FLT PET for Non-Invasive Assessment of Tumor Sensitivity to Chemotherapy: Studies with Experimental Chemotherapy TP202377 in Human Cancer Xenografts in Mice

AIM: 3′-deoxy-3′-[(18)F]fluorothymidine ([18F]FLT) is a tracer used to assess cell proliferation in vivo. The aim of the study was to use [18F]FLT positron emission tomography (PET) to study non-invasively early anti-proliferative effects of the experimental chemotherapeutic agent TP202377 in both s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munk Jensen, Mette, Erichsen, Kamille Dumong, Björkling, Fredrik, Madsen, Jacob, Jensen, Peter Buhl, Sehested, Maxwell, Højgaard, Liselotte, Kjær, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511543/ https://www.ncbi.nlm.nih.gov/pubmed/23226334 http://dx.doi.org/10.1371/journal.pone.0050618

Ejemplares similares

Imaging of Treatment Response to the Combination of Carboplatin and Paclitaxel in Human Ovarian Cancer Xenograft Tumors in Mice Using FDG and FLT PET
por: Munk Jensen, Mette, et al.
Publicado: (2013)

Early Detection of Response to Experimental Chemotherapeutic Top216 with [(18)F]FLT and [(18)F]FDG PET in Human Ovary Cancer Xenografts in Mice
por: Munk Jensen, Mette, et al.
Publicado: (2010)

[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
por: Jensen, Mette Munk, et al.
Publicado: (2013)

[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts
por: Munk Jensen, Mette, et al.
Publicado: (2013)

Monitoring the effect of belinostat in solid tumors by H4 acetylation
por: MARQUARD, LENA, et al.
Publicado: (2008)

(18)F-FDG and (18)F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice
por: Bardram Johnbeck, Camilla, et al.
Publicado: (2014)

Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by (18)F-FDG-microPET or external caliper
por: Jensen, Mette Munk, et al.
Publicado: (2008)

Chemotherapy of human breast-carcinoma xenografts.
por: Bailey, M. J., et al.
Publicado: (1980)

Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase
por: Olesen, Uffe H, et al.
Publicado: (2010)

Chemotherapy-radiation interactions in human cervix carcinoma xenografts.
por: Tonkin, K. S., et al.
Publicado: (1988)

The response to chemotherapy of a variety of human tumour xenografts.
por: Steel, G. G., et al.
Publicado: (1983)

Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.
por: Nowak, K., et al.
Publicado: (1978)

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
por: Kim, Jin-Ah, et al.
Publicado: (2023)

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
por: Stuckey, Ashley, et al.
Publicado: (2011)

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells
por: Dejligbjerg, Marielle, et al.
Publicado: (2008)

Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours
por: Hoh, C K, et al.
Publicado: (2014)

Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD(+) acute myeloid leukemia
por: Ueno, Yoko, et al.
Publicado: (2019)

Potential Effects of the FLT3-ITD Mutation on Chemotherapy Response and Prognosis of Acute Promyelocytic Leukemia
por: Song, Yu-hua, et al.
Publicado: (2021)

Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
por: Schmidt, Franziska, et al.
Publicado: (2022)

Experimental combination and single-agent chemotherapy in human lung-tumour xenografts.
por: Shorthouse, A. J., et al.
Publicado: (1982)

Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
por: Tao, Hao-Yun, et al.
Publicado: (2021)

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model
por: Milazzo, Claudia, et al.
Publicado: (2021)

Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [(18)F]FLT-PET Imaging
por: Viel, Thomas, et al.
Publicado: (2013)

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia
por: Hosono, Naoko, et al.
Publicado: (2021)

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications
por: Döhner, Hartmut, et al.
Publicado: (2022)

In vivo imaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography
por: Nielsen, Carsten H., et al.
Publicado: (2015)

Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.
por: Selby, P. J., et al.
Publicado: (1980)

Enhanced Efficacy of Radioimmunotherapy Combined with Systemic Chemotherapy and Local Hyperthermia in Xenograft Model
por: Kinuya, Seigo, et al.
Publicado: (2000)

High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts
por: Kim, Hyunsoo, et al.
Publicado: (2018)

Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX)
por: Malcolm, Joan E., et al.
Publicado: (2019)

Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells
por: Jensen, Lars H, et al.
Publicado: (2004)

Loss of MiR-155 Sensitizes FLT3-ITD(+)AML to Chemotherapy and FLT3 Inhibitors via Glycolysis Blocking by Targeting PIK3R1
por: Wang, Lingyan, et al.
Publicado: (2023)

PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS
por: Navickas, A., et al.
Publicado: (2022)

RESOLUTE PET/MRI Attenuation Correction for O-(2-(18)F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants
por: Ladefoged, Claes N., et al.
Publicado: (2017)

Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
por: Wang, Piwen, et al.
Publicado: (2016)

Advantages in Combination Chemotherapy Using Cisplatin and Its Analogues for Human Testicular Tumor Xenografts
por: Hida, Shuichi, et al.
Publicado: (1990)

Patient-related healthcare disparities in the quality of acute hip fracture care: a 10-year nationwide population-based cohort study
por: Kristensen, Pia Kjær, et al.
Publicado: (2021)

Site-specifically labeled (89)Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model
por: Kristensen, Lotte K., et al.
Publicado: (2019)

Pharmacokinetic Analysis of (64)Cu-ATSM Dynamic PET in Human Xenograft Tumors in Mice
por: Li, Fan, et al.
Publicado: (2015)

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia
por: Cummins, K D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2t7eov99bgva013d24eeittva2